Substance use and psychiatric comorbidities among medical inpatients: associations with length of stay, health-related quality of life, and functioning, with consideration for gender

Resum

Little is known about the impact of substance use and psychiatric comorbidities on the management and outcomes of medical inpatients. This study explores the influence of psychiatric comorbidities, and substance use (tobacco, alcohol, and cannabis) on the length of hospital stay (LOS), Health-Related Quality of Life (HRQoL), and functioning in 800 medical inpatients at a high-complexity academic hospital. Multivariate analyses demonstrated that psychiatric comorbidities were associated with reduced HRQoL (beta = -0.050, p-value = 0.017), and impaired functioning (beta = 3.4, p-value

Tipus de document

Article


Versió acceptada

Llengua

Anglès

Publicat per

Elsevier Ltd.

Documents relacionats

Versió postprint del document publicat a: https://doi.org/10.1016/j.jpsychires.2025.04.006

Journal Of Psychiatric Research, 2025, vol. 186, 322-330

https://doi.org/10.1016/j.jpsychires.2025.04.006

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

cc-by-nc-nd (c) Elsevier, 2025

http://creativecommons.org/licenses/by-nc-nd/3.0/es/

Aquest element apareix en la col·lecció o col·leccions següent(s)